Kazuyuki Nakagome

New Capabilities

As of October 2026: Leads the institute that co-discovered brogidirsen and ran the first-in-human trial

Six boys with Duchenne muscular dystrophy have taken weekly doses of brogidirsen for five years. New data presented at the World Muscle Society congress in Hiroshima shows their motor function held steady and no serious side effects appeared.

Updated Oct 1